Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 10, 2009, Pages 3958-3963

  El Chemaly, Souheil ^a   Malide, Daniela ^a   Zudaire, Enrique ^b   Ikeda, Yoshihiko ^a,e   Weinberg, Benjamin A ^a   Pacheco Rodriguez, Gustavo ^a   Rosas, Ivan O ^a,f   Aparicio, Marta ^b   Ren, Ping ^a   MacDonald, Sandra D ^a   Wu, Hai Ping ^a   Nathan, Steven D ^c   Cuttitta, Frank ^b   McCoy, J Philip ^a   Gochuico, Bernadette R ^d   Moss, Joel ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INOVA HEART AND VASCULAR INSTITUTE   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endothelial cell; Hyaluronan; Idiopathic pulmonary fibrosis; Lymphangiogenesis; Macrophage

Indexed keywords

CD11B ANTIGEN; FIBROBLAST GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; LYVE 1 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; PODOPLANIN; SCATTER FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROBLAST; LUNG LAVAGE; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLUNTEER;

ANTIGENS, CD11B; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; ENDOTHELIAL CELLS; HEALTH; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; IDIOPATHIC PULMONARY FIBROSIS; LYMPHANGIOGENESIS; MACROPHAGES; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY ALVEOLI; VESICULAR TRANSPORT PROTEINS;

EID: 62649119619     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0813368106     Document Type: Article

References (43)

1. Walter N, Collard HR, King TE Jr. (2006) Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3:330-338.
2. Marchal-Somme J, et al. (2006) Cutting edge: Nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 176:5735-5739.
3. Selman M, Pardo A (2006) Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers. Proc Am Thorac Soc 3:364-372.
4. Matsui K, et al. (2003) Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: Aminopeptidase P and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14:1981-1989.
5. Teles-Grilo ML, et al. (2005) Differential expression of collagens type I and type IV in lymphangiogenesis during the angiogenic process associated with bleomycin-induced pulmonary fibrosis in rat. Lymphology 38:130-135.
6. Maruyama K, et al. (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363-2372.
7. Kajiya K, Detmar M (2006) An important role of lymphatic vessels in the control of UVB-induced edema formation and inflammation. J Invest Dermatol 126:919-921.
8. Kerjaschki D, et al. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15:603-612.
9. Kerjaschki D, et al. (2006) Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12:230-234.
10. Ristimaki A, et al. (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418.
11. Jiang D, et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173-1179.
12. Prevo R, et al. (2001) Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276:19420-19430.
13. Kamei M, et al. (2006) Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 442:453-456.
14. Hamai A, Morikawa K, Horie K, Tokuyasu K (1989) Purification and characterization of hyaluronidase from Streptococcus dysgalactiae. Agric Biol Chem 53:2163-2168.
15. Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: An information-rich system. Eur J Cell Biol 85:699-715.
16. Schaberg T, Rau M, Stephan H, Lode H (1993) Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Am Rev Respir Dis 147:1507-1513.
17. Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3:367-397.
18. Maruyama K, et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170:1178-1191.
19. Ren P, et al. (2007) Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 175:1151-1157.
20. Savani RC, et al. (2000) A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am J Respir Cell Mol Biol 23:475-484.
21. Zhang-Hoover J, Sutton A, van Rooijen N, Stein-Streilein J (2000) A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis. Immunology 101:501-511.
22. Cursiefen C, et al. (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25:443-447.
23. Baluk P, et al. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115:247-257.
24. Garantziotis S, et al. (2008) Serum inter-{alpha}-trypsin unhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury. Am J Respir Crit Care Med 178:939-947.
25. Jiang D, Liang J, Noble PW (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23:435-461.
26. Bjermer L, Lundgren R, Hallgren R (1989) Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44:126-131.
27. Savani RC, et al. (2001) Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 276:36770-36778.
28. Nedvetzki S, et al. (2004) RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy. Proc Natl Acad Sci U S A 101:18081-18086.
29. Karkkainen MJ, et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80.
30. Makinen T, et al. (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7:199-205.
31. Bromley SK, Thomas SY, Luster AD (2005) Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6:895-901.
32. Pierce EM, et al. (2007) Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 29:1082-1093.
33. Avraamides CJ, Garmy-Susini B, Varner JA (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8:604-617.
34. Zwaans BM, Bielenberg DR (2007) Potential therapeutic strategies for lymphatic metastasis. Microvasc Res 74:145-158.
35. Gauldie J, Kolb M (2008) Animal models of pulmonary fibrosis: How far from effective reality? Am J Physiol Lung Cell Mol Physiol 294:L151.
36. Sasaki M, et al. (2003) Antagonist of secondary lymphoid tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol 170:588-596.
37. Jensen KK, et al. (2003) Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol 77:624-630.
38. (2000) American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement, American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646-664.
39. (2002) American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277-304.
40. Van der Auwera I, et al. (2006) First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 95:1611-1625.
41. Miyata Y, et al. (2006) Lymphangiogenesis and angiogenesis in bladder cancer: Prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res 12:800-806.
42. Monzon ME, Casalino-Matsuda SM, Forteza RM (2006) Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 34:135-141.
43. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics Int 11:36-42.